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Abstract. 
 
Fibroblast growth factors and receptors are in-
timately connected to the extracellular matrix by their af-
ﬁnity to heparan sulfate proteoglycans. They mediate
multiple processes during embryonic development and
adult life. In this study, embryonic stem cell–derived em-
bryoid bodies were used to model ﬁbroblast growth factor
signaling during early epithelial morphogenesis. To avoid
redundancy caused by multiple receptors, we employed a
 
dominant negative mutation of
 
 Fgfr2
 
. Mutant-derived
 
embryoid bodies failed to form endoderm, ectoderm, and
basement membrane and did not cavitate. However, in
mixed cultures they displayed complete differentiation
induced by extracellular products of the normal cell. Evi-
dence will be presented here that at least one of these
products is the basement membrane or factors connected
to it. It will be shown that in the mutant, collagen IV and
laminin-1 synthesis is coordinately suppressed. We will
demonstrate that the basement membrane is required for
 
embryoid body differentiation by rescuing columnar ec-
toderm differentiation and cavitation in the mutant by
externally added basement membrane proteins. This
 
treatment induced transcription of 
 
Eomesodermin
 
,
 
 
 
an
early developmental gene, suggesting that puriﬁed base-
ment membrane proteins can activate inherent develop-
mental programs. Our results provide a new paradigm
for the role of ﬁbroblast growth factor signaling in base-
ment membrane formation and epithelial differentiation.
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Introduction
 
Fibroblast growth factors (FGFs)
 
1
 
 and their tyrosine ki-
nase receptors (FGFR) are involved in multiple physio-
logical and pathological processes. They are important
throughout embryonic development as well as in angio-
genesis and wound healing. FGFR mutations cause defec-
tive bone and craniofacial development and are associated
with cancer (Wilkie, 1997; Cappellen et al., 1999). A com-
mon denominator of these multiple activities links the
FGF system with the extracellular matrix (ECM) and with
epithelial mesenchymal interactions.
Various FGF isotypes bind heparan sulfate proteogly-
cans (HSPGs) of the ECM and basement membrane
(BM). A molecular mechanism for these interactions was
revealed by crystallographic evidence, showing that FGFR
dimers and their ligands form a specific groove for HSPG
binding. This triple complex of FGF, FGFR, and HSPG
represent the FGF signaling unit (Plotnikov et al., 1999).
Additional important signaling molecules, such as 
 
wnt
 
 and
 
hedgehog
 
, also have affinity to HSPGs (for a review see
Perrimon and Bernfield, 2000). Therefore, the HSPG-
bearing ECM and BM may serve as platforms for growth
factor signaling.
Localization and binding specificity of FGF and FGFR
indicate that they signal across cell sheets separated by the
BM. Splice variants of 
 
Fgfr2 
 
and other FGFR loci display
specific localization. So-called “b-type” splicing alterna-
tives are expressed in epithelia, whereas “c-type” receptors
are expressed in the mesenchyme (Orr-Urtreger et al.,
1993). Most FGF are bound either by b or by c type recep-
tors (Ornitz et al., 1996). Due to their localized expression
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Abbreviations used in this paper:
 
 BM, basement membrane; ECM, ex-
tracellular matrix; ES, embryonic stem; FGF, fibroblast growth factor;
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mEomes
 
, mouse 
 
Eomesodermin
 
;
RT, reverse transcription. 
The Journal of Cell Biology, Volume 153, 2001 812
 
and binding specificity, epithelial FGFRs interact with
mesenchymal ligands, whereas mesenchymal receptors rec-
ognize epithelial FGFs. This coordination between tran-
scriptional localization and binding specificity may have
developed to promote epithelial mesenchymal interactions.
Genetic evidence for FGF-mediated epithelial mesen-
chymal interactions was obtained in limb development.
The b variant of 
 
Fgfr2
 
 is expressed in the epithelium of the
apical ectodermal ridge, whereas its ligand, Fgf10, in the
progress zone mesenchyme and its loss of function muta-
tions display similar phenotypes (Arman et al., 1999; Se-
kine et al., 1999; De Moerlooze et al., 2000). Additional
functional connections of the FGF system with the ECM
are associated with morphogenic cell migration. FGFR ho-
mologues are required for trachea and mesoderm migra-
tion in Drosophila (Beiman et al., 1996) and for sex myo-
blast migration in 
 
Caenorhabditis elegans 
 
(DeVore et al.,
1995), whereas in the gastrulating mouse embryos, 
 
Fgfr1 
 
is
responsible for cell migration through the primitive streak
(Ciruna et al., 1997). Further molecular connection be-
tween FGFRs and the ECM was based on the aggregation
of integrins with FGFR at sites of intracellular phosphory-
lation (Miyamoto et al., 1996).
A series of data on epithelial differentiation join these
findings and argue for a functional role of the BM. Evi-
dence derives from differentiation induction by BM com-
ponents (for a review see Ashkenas et al., 1996), from inhi-
bition of differentiation by antibodies specific to BM
proteins and their receptors (Klein et al., 1988; Durbeej et
al., 1995; Kadoya et al., 1995; Schuger et al., 1995) and
from the targeted mutagenesis of genes encoding them
(Fassler et al., 1995; Stephens et al., 1995; Williamson et
al., 1997; Murray and Edgar, 2000).
We were interested in a further exploration of the link
between FGF signaling and the ECM. It was recently dem-
onstrated that truncated Fgfr2 cDNA expressed in embry-
onic stem (ES) cells inhibits their differentiation and ab-
rogates FGF signaling through the phosphatidylinositol
(PI)-3 kinase–Akt/PKB pathway (Chen et al., 2000). The
experiments to be described here investigate the cellular
mechanism of this dominant negative mutation. We will
demonstrate that ES cells expressing the truncated Fgfr2
cDNA can recognize an extracellular differentiation signal
produced by wild-type cells. We will also show that loss of
FGFR function abrogates laminin-1 and collagen IV syn-
thesis and that externally added laminin-1 or Matrigel can
rescue ectoderm differentiation and cavitation. Our data
collectively suggest that FGF signaling contributes to the
regulation of BM formation. To our knowledge, these data
suggest a previously unrecognized type of connection be-
tween FGF signaling and the ECM and offer testable par-
adigms for the mechanism of epithelial morphogenesis.
 
Materials and Methods
 
Embryoid Bodies
 
Mutant ES cell clones were derived from the ROSA11 line, expressing the
 
b
 
-geo cassette. As a control, ROSA11, or its ancestor the AB2.2 ES cell
line (a gift of A. Bradley, Anderson Cancer Center, Houston, Texas) that
has no reporter, were cultured as described
 
 
 
previously (Chen et al., 2000).
In brief, undifferentiated stem cells were seeded first on
 
 
 
tissue culture
plates for 24 h to remove residual feeder cells. The cell clumps formed
 
were then detached by pipetting and transferred to bacteriological dishes.
The day of transfer of primary aggregates was denominated as day 0.
 
Dominant Negative Mutation
 
Fgfr2 cDNA was truncated downstream of the transmembrane domain
(from nucleotide 650 to 2,069) and was controlled by the EF-1a promoter.
Details of the construct and selection of high expressing clones was as de-
scribed (Chen et al., 2000).
 
Teratomas
 
129/Pas mice were injected subcutaneously with 5 
 
3 
 
10
 
6
 
 wild-type or mu-
tant ES cells. Teratocarcinomas were dissected after 2–3 wk of growth,
when their diameter reached 0.5–1.5 cm.
 
Cytology and Histology
 
For semithin sections, embryoid bodies were washed twice in PBS, fixed
in 4% paraformaldehyde at 4
 
8
 
C overnight, and after dehydration in etha-
nol were embedded in JB-4 resin (Polysciences, Inc.). 1–4-
 
m
 
m sections
were cut with a glass knife. For cytology, the sections were stained with
toluidine blue. In cell mixing experiments, the embryoid bodies were pre-
fixed and stained for 
 
b
 
-galactosidase and the sections were counterstained
with neutral red. Teratocarcinomas were fixed in Bouin fixative, embed-
ded in Paraplast, and the sections were stained with hematoxylin and
eosin. Microphotography was with a ZEISS Axiomat microscope. Films
were scanned and figures were prepared with Photoshop 5.5 software.
 
Treatment with Externally Added BM Proteins
 
Matrigel (growth factor reduced; Becton Dickinson) was added in solution
for the first day of culture. Matrigel, which in general is used as a concen-
trated semisolid gel, was here used as a 4% (vol/vol) solution with the float-
ing ES cell aggregates. Purified laminin-1–nidogen complex (a gift of Dr. R.
Timpl, Max-Planck Institute for Biochemistry, Martinsried, Germany) was
added to the cultures for the first day in a concentration of 50–100 
 
m
 
g/ml.
Collagen IV was from Sigma-Aldrich (C0543). It was used at a final con-
centration of 3.0 
 
m
 
g/ml that approximates its concentration in Matrigel.
 
Antibodies
 
The MAB371 dystroglycan specific antibody was a gift from Chemicon In-
ternational. Antibody specific to fibronectin was from Sigma-Aldrich
(F3648), to integrin-
 
a
 
6 and integrin-
 
b
 
1 from BD PharMingen (MAB
GoH3 and CD29, respectively), to perlecan from Chemicon International
(MAB no. 1948), and to collagen IV from Chemicon International
(AB756P). The nidogen-1 antibody was a gift of Dr. R. Timpl (Martins-
ried, Germany). The laminin-
 
a
 
1–specific Mab200 antibody was described
previously (Kadoya et al., 1995). Cy-3–labeled secondary antibodies were
from Jackson ImmunoResearch Laboratories. Fluoresceinated phalloidin
was from Sigma-Aldrich (P1951).
 
Confocal Analysis
 
Embryoid bodies were washed twice in PBS and fixed in cold 4% parafor-
maldehyde for 20 min at room temperature. After washing twice with
PBS, fixed embryoid bodies were permeabilized with 1% Triton X-100
and 10% BSA in PBS for 10 min at room temperature, followed by re-
peated washing in PBS.
 
 
 
Antibodies were diluted in PBS and 3% BSA. The
same solution was used for blocking (30 min). The primary antibody was
added in microdrops for 1 h, followed by five washes in PBS containing
3% BSA. Incubation with Cy-3–labeled secondary antibodies or with fluo-
resceinated phalloidin was for 30 min, followed by five washes. Stained
embryoid bodies were pipetted into a well cut into a Perspex microscope
slide that was covered at one side by a coverslip. Mineral oil was layered
on the suspension and the embryoid bodies were observed, as whole
mounts, in a Bio-Rad Laboratories 1024 confocal inverted microscope.
Each embryoid body was inspected through multiple optical sections.
 
RNA Blot Hybridization
 
Embryoid bodies or ES cells were recovered from culture and washed in
PBS. Lysis and RNA extraction was with the RNeasy kit (QIAGEN). 10
 
m
 
g total RNA was denatured in glyoxal and separated on a denaturing gel.
Posthybridization wash was in 0.1
 
3
 
 SSC at 68
 
8
 
C. The following DNA 
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probes were used: for laminin-
 
a
 
1, a 532-bp fragment (residues 313–835),
and for collagen 
 
a
 
1 (IV), a 400-bp fragment (residues 3,254–3,653) was
synthesized by reverse transcription (RT)-PCR. Laminin-
 
b
 
1, dystrogly-
can, fibronectin, perlecan, and nidogen-1 probes have been used as de-
scribed (Ekblom et al., 1990; Ibraghimov-Breskovnaya et al., 1992; Talts
et al., 1995; Costell et al., 1999).
 
In Situ Hybridization
 
Nonradioactive in situ hybridization was according to established methods
(Conlon and Herrmann, 1992) with small modifications. In brief, embry-
oid bodies were collected, washed in PBS, and fixed in cold 4% parafor-
maldehyde for 2 h. After short dehydration in methanol, they were stored
at 
 
2
 
20
 
8
 
C. The reaction was started by rehydration to increase permeabil-
ity. Protease treatment for vHNF1 and mouse 
 
Eomesodermin 
 
(
 
mEomes
 
)
was with 2 
 
m
 
g/ml proteinase K for 10 min. For in situ hybridization with
vHNF (Barbacci et al., 1999), a cDNA fragment (residues 948–1,354) was
synthesized by RT-PCR.
 
 
 
The
 
 
 
cDNA probe for 
 
Brachiury
 
 was from B.
Herrmann (MPI for Immunobiology, Freiburg, Germany), for 
 
ptc 
 
from
M. Scott (Stanford, University, Stanford, CA), for 
 
Gli-1 
 
from A. Joyner
(NYU Medical Center, New York, NY), for 
 
cripto-1
 
 from A. Simeone (In-
ternational Institute of Genetics and Biophysics, Naples, Italy), for BMP4
and BMP2 from G. Martin (University of California, San Francisco, San
Francisco, CA), and for 
 
mEomes 
 
from J. Rossant (Lumenfeld Institute,
Toronto, Ontario, Canada
 
). 
 
Hybridization conditions, such as the dura-
tion of protease treatment, dehydration, and hybridization with “sense”
transcripts, were fine-tuned on wild-type embryoid bodies before the de-
tailed experiment. After color reaction, embryoid bodies were quickly de-
hydrated in ethanol and embedded in plastic. 5–10-
 
m
 
m sections were
counterstained with neutral red.
 
RT-PCR
 
Total RNA was isolated from ES cells or embryoid bodies with RNAzol B
(Tel-Test, Inc.). RT-PCR was performed with the Titan RT-PCR System
(Boehringer). Denaturation was for 30 s at 94
 
8
 
C, annealing for 30 s at 50–
60
 
8
 
C, and synthesis for 1 min at 72
 
8
 
C. Primers, annealing temperature, and
cycles for 
 
b
 
-HI globin were: AGTCCCCATGGAGTCAAAGA and
CTCAAGGAGACCTTTGCTCA with 40 cycles at 55
 
8
 
C; for Flk1, GTG-
GATCTGAAAAGACGC and CATTCTTCTCCGATAGG with 40 cy-
cles at 50
 
8
 
C; and for kit ligand (KL), GACTGTGTGCTCTCTTCAAC
and CTTGCAAAACCTCCAGAGTC with 45 cycles at 50
 
8
 
C.
 
Results
 
Truncated Fgfr2 cDNA Abrogates Differentiation 
of Both Cell Layers of the Embryoid Body
 
In a previous study, Fgfr2 cDNA, truncated downstream
of the transmembrane exon and controlled by the EF-1a
promoter,
 
 
 
was introduced into
 
 
 
ROSA11
 
 
 
ES cells that con-
tain the 
 
b
 
-galactosidase reporter (Chen et al., 2000). Wild-
type cells developed into cystic embryoid bodies (Fig. 1
A), whereas ES cell clones expressing the truncated, dom-
inant negative FGFR cDNA formed compact bodies that
failed to cavitate (Fig. 1 B). To obtain morphological de-
tail, embryoid bodies were embedded in plastic and tolui-
dine blue–stained semithin sections were prepared. Wild-
type embryoid bodies displayed two cell layers (Fig. 1 C).
A visceral endoderm-like polar surface epithelium cov-
ered the internal epiblast-like columnar ectoderm and the
two cell layers, separated by a BM, surrounded a well-
defined cavity (Fig. 1 D). At the start of differentiation,
both wild-type and mutant ES cells formed aggregates.
The aggregates expanded during the first 2 d of culture,
and on the surface of the wild-type embryoid body endo-
derm appeared on the third day. Columnar ectoderm and
the first signs of cavitation manifested at late day 3 or 4,
and cavitation became complete by day 6. After aggregates
have been formed, mutant-derived embryoid bodies ceased
to differentiate further and did not form columnar ecto-
derm (Fig. 1, E and F). Mutant embryoid bodies grew and
survived for 6 or 8 d, after which they declined. Larger mu-
tant embryoid bodies developed necrotic foci, but no cavi-
tation took place (Fig. 1 F).
As a molecular parameter of visceral endoderm differ-
entiation, we assayed vHNF1 transcription by in situ hy-
bridization. Variant HNF1 is an early visceral endoderm
marker (Barbacci et al., 1999) that was transcribed by
wild-type, but not by mutant-derived embryoid bodies
(Fig. 2, A and B). This result joined previous data on addi-
tional visceral endoderm markers, such as HNF4, Evx1,
and 
 
a
 
-fetoprotein, which were also suppressed in our mu-
tant (Chen et al., 2000).
Mature cystic embryoid bodies undergo embryonic he-
mopoiesis and vasculogenesis (Risau et al., 1988). We in-
vestigated whether the dominant negative FGFR mutant
will undergo this line of differentiation. RT-PCR analysis
revealed that neither embryonic globin nor 
 
Flk-1
 
, or stem
cell factor (
 
kit
 
 ligand), were transcribed in the mutant,
whereas they were copiously expressed by the wild-type
(Fig. 2 C). It follows that morphologically undifferentiated
mutant embryoid bodies cannot contribute to gastrula-
tion-associated gene expression.
To investigate whether the dominant negative mutation
has in vivo effects, ES cells were transplanted subcutane-
ously into strain 129 mice. Wild-type ES cells formed ter-
atomas containing cartilage (Fig. 3 A), polar epithelium
(Fig. 3 B), and muscle (Fig. 3 C), whereas the mutant grew
into undifferentiated tumors, save a few scattered epithe-
lial vessels (Fig. 3 D). It follows that defective FGF signal-
ing deeply abrogates ES cell differentiation both in vitro
and in vivo.
 
The Mutant Can Recognize a Differentiation 
Factor, but Cannot Produce It
 
We prepared mixed cultures to investigate the cellular
mechanism of our mutation. This arrangement allowed
testing whether the mutant defect resides within the mu-
tant cell or outside of it in products secreted by its wild-
type neighbors. Single cell suspensions of various ES cell
lines were mixed at the onset of culture. Two wild-type ES
cell lines, the 
 
b
 
-galactosidase–positive ROSA11 (Fig. 4 A)
and the 
 
b
 
-galactosidase–negative AB2.2 clone (Fig. 4 B),
and one mutant cell line (Fig. 4 C), the 
 
b
 
-galactosidase–
positive, 1C3 clone (Chen et al., 2000), were used. We
made two kinds of chimeric embryoid bodies. As control,
the two wild-type cell lines colonized both cell layers to
similar extent (Fig. 4 D). In the experimental chimera,
which contained 
 
b
 
-galactosidase–labeled mutant and unla-
beled wild-type cells, the mutant colonized both cell layers
and mutant-derived fragments were detectable in the cen-
tral, apoptotic
 
 
 
cavity (Fig. 4 E). Almost 80% of the experi-
mental embryoid bodies contained differentiated mutant
cells (Table I). It follows that the mutant, if it receives an
extracellular signal from its wild-type neighbors, can dif-
ferentiate into both endoderm and ectoderm and partici-
pates in apoptotic cavitation.
To investigate the radius of action of this extracellular
signal (or signals), wild-type and mutant ES cells were
grown separately until primary aggregates formed and 
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only then were mixed and incubated for five more days.
This arrangement limited the contact between wild-type
and mutant cells. Counting fused aggregates revealed that
only a third contained a few scattered differentiated mu-
tant cells (Fig. 4 F and Table II). We conclude that to be
effective, the extracellular factor had to be close to the
mutant cell or make actual contact with it.
These results are interpreted to suggest that the mecha-
nism of the dominant negative FGFR mutation is “non–
cell autonomous.” That is, the mutant cannot produce, but
can recognize an extracellular signal that is secreted by the
wild-type. We assumed that this factor is a cell adhesion
structure, or an element of ECM. First, E-cadherin, an
adhesion receptor of embryonic cells, was investigated.
E-cadherin is required for compaction of the mouse morula
and for ES cell aggregation at the onset of embryoid body
differentiation (Larue et al., 1994). However, there was no
significant difference in E-cadherin expression between
wild-type and mutant. Next, we sought indications for the
involvement of the integrin family and investigated the
activation of focal adhesion kinase (FAK), one of the cy-
toplasmic protein kinases of the integrin pathway (Schlaep-
fer and Hunter, 1998). When no significant difference was
found, we decided to explore whether the dominant nega-
tive mutation affects the BM.
 
The FGFR Mutation Inhibits Laminin-1 
and Collagen IV Expression
 
We first compared the localization and expression of in-
dividual BM-related proteins in wild-type and mutant
embryoid bodies by confocal immunofluorescence mi-
croscopy. Three groups of BM-associated proteins were
investigated. Among the receptors of collagen IV and
laminin-1, dystroglycan (Fig. 5, A and B), integrin-
 
a
 
6 (Fig.
5, E and F), and integrin-
 
b
 
1 were studied. BM-associated
proteins were detected by antibodies to fibronectin (Fig. 5,
C and D), nidogen-1 (Fig. 5, G and H), or perlecan (Fig. 5,
K and L). Network-forming proteins of the BM were visu-
alized by anti–laminin-
 
a
 
1 (Fig. 5, I and J) or anti–collagen
IV (Fig. 5, M and N). Morphological detail was supplied
by fluoresceinated phalloidin, which detects the actin cy-
toskeleton.
Laminin-
 
a
 
1, nidogen-1, and fibronectin localized in the
BM of wild-type embryoid bodies as early as the second
day of culture (Fig. 5, O–R). These proteins, as well as col-
lagen IV (Fig. 5 M) and perlecan (Fig. 5 K), concentrated
Figure 1. The dominant negative FGFR mutation abrogates embryoid body differentiation. Cellular morphology of embryoid bodies.
Comparison between wild-type (A, C, and D) and mutant (B, E, and F). (A and B) Stereomicroscope view; (C–F) semithin sections.
The mutant does not undergo ectoderm and endoderm differentiation and does not cavitate. Bars: (A and B) 75 mm; (C–F) 25 mm.
 
Table I. The Dominant Negative Mutant Cannot Make, but Can 
Recognize a Differentiation Factor Produced by the Wild-Type
 
Mixed embryoid bodies
No. embryoid
bodies counted Percentage
 
With differentiated mutant cells 90 76.9
With undifferentiated mutant cells 27 23.1
Total 117 100.0
 
Table II. The Differentiation Signal Acts Across a 
Short Distance
 
Embryoid bodies
containing mutant cells
State of mutant cells
in the embryoid body
Total Differentiated Undifferentiated
 
Nonfused 145 0 145 (100%)
Fused 86 29 (33.7%)* 57 (66.3%)
Total 231
 
Primary aggregates (5–20 cells) of mutant and wild-type ES cells were mixed and
grown for 6 d and embryoid bodies containing LaZ-positive differentiated or
undifferentiated cells were counted.
*Not 
 
.
 
1–5 differentiated mutant cells were found in these fused embryoid bodies. 
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in the BM, between the endoderm and ectoderm. Dystro-
glycan was detected both in the endoderm and ectoderm
(Fig. 5 A). Integrin-
 
a
 
6 localized exclusively to the ecto-
derm (Fig. 5 E), whereas integrin-
 
b
 
1 was found in the sur-
face endoderm (not shown). Hence, laminin receptors
were present in both cell layers of the wild-type embryoid
body. In contrast to wild-type, no BM could be detected in
mutant embryoid bodies and the specific proteins, such as
integrin-
 
a
 
6 (Fig. 5 F), dystroglycan (Fig. 5 B), fibronectin
(Fig. 5 D), nidogen-1 (Fig. 5 H), and perlecan (Fig. 5 K),
were all distributed as a diffuse, punctuate label.
 
The central finding of this investigation was that two
network-forming proteins of the BM, laminin-
 
a
 
1 (Fig. 5 J)
and collagen IV (Fig. 5 N), were either undetectable, or
gave only weak signals in mutant-derived embryoid bod-
ies. The results suggest that due to defective FGF signal-
ing, the expression of laminin-
 
a
 
1 and the collagen IV iso-
forms was selectively lost as detected by our antibodies,
whereas several other BM-related proteins remained ex-
pressed, albeit in a disorganized manner. It follows that in-
tact FGF signaling may be required for the expression of
these essential network-forming components of the BM.
To obtain additional evidence, transcription of BM com-
ponents was investigated by RNA blot hybridization. Perle-
can, fibronectin, nidogen-1, and dystroglycan transcripts
were detectable in both mutant and wild-type ES cells and
embryoid bodies (Fig. 6). However, laminin-
 
a
 
1, laminin-
 
b
 
1,
and collagen 
 
a
 
1 (IV) transcripts were absent in the mutant,
or they were detectable only in greatly reduced amounts. It
follows that loss of FGFR function leads to the coordinate
loss of laminin-1 and collagen 
 
a
 
1 (IV) expression.
 
Partial Rescue of the Dominant Negative Mutation by 
Matrigel and Laminin-1
 
We showed above that the FGFR defect of embryoid body
differentiation is non–cell autonomous and coincides with
the loss of network-forming BM proteins. We next asked
whether the BM, or purified BM proteins, are required for
embryoid body differentiation. The answer to this ques-
tion was sought in the effect of externally added BM pro-
teins on wild-type and mutant embryoid bodies (Fig. 7, A
and B).
First, growth factor–reduced Matrigel, a commercial
preparation of BM proteins, was used. Matrigel at a con-
centration of 4% (vol/vol), was added for the first 24 h. Af-
ter an additional 5 d, close to 70% of Matrigel-treated
mutant embryoid bodies (25–80%, in eight different ex-
periments) formed a continuous columnar ectoderm layer
with normal, but somewhat smaller cavities than the wild-
type (Fig. 7 C and Table III),
 
 
 
whereas without Matrigel no
differentiation took place (Fig. 7 A).
 
 
 
Similar results, al-
though at somewhat lower frequency, were obtained when
50–100 
 
m
 
g/ml of a purified laminin-1–nidogen complex
(Paulsson et al., 1987) was added to the cultures (Table
III). Laminin-1–treated cells, similarly to Matrigel treat-
ment, grew to embryoid bodies, displayed columnar ecto-
derm on their surface, and 15–30% underwent cavitation
but developed no visceral endoderm (Fig. 7 E and Table
III). In contrast to Matrigel and laminin-1 treatment, col-
lagen IV had no effect (not shown).
The laminin-1 preparation used here is a highly purified
protein fraction (Paulsson et al., 1987; Fässler et al., 1995),
and the Matrigel used was depleted in growth factors.
Nevertheless, to exclude the role of growth factor contam-
ination, the mutant was treated with insulin, EGF, FGF2,
and PDGF-BB in concentrations far exceeding possible
contamination in both preparations (Table IV). However,
this had no effect as judged by morphological criteria.
It was unexpected that both Matrigel and laminin-1–
treated mutant embryoid bodies failed to form visceral en-
doderm (Fig. 7, C and E). As a control, wild-type cultures
were also treated with Matrigel or laminin-1. The results
Figure 2. The dominant negative mutation abolishes lineage-
specific markers. (A and B) In situ hybridization with vHNF1 (A,
wild type; B, mutant). Bar: 50 mm. Note the lack of vHNF1 tran-
scription in the mutant. (C) RT-PCR analysis, b-HI embryonic
globin; Flk1, vascular endothelial growth factor (VEGF) recep-
tor; KL, kit ligand; 1C3, a dominant negative ES cell clone; R11,
ROSA11 wild-type ES cells; M, marker. Note that mutant cul-
tures transcribe these hemopoietic and angiogenic markers at
very low levels. 
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Figure 3. The FGFR mutation abrogates differentiation in vivo. (A–C) Wild-type and (D) mutant-derived teratomas. Bars: (A–D) 50
mm. Mutant teratomas undergo little or no differentiation (D), whereas the wild-type forms cartilage (A), ciliar epithelium (B), and
muscle (B). ca, cartilage; ec, ectoderm; ep, ciliated epithelium; mf, muscle fiber.
Figure 4. Mutant cells can recognize, but cannot produce an extracellular differentiation factor. Embryoid bodies grown for 6 d from
(A–C) individual cell lines or from (D–F) mixed ES cell cultures. Origin of embryoid bodies: (A) b-galactosidase–positive wild-type
ROSA 11 cells; (B) b-galactosidase–negative, AB2.2 wild-type cells; (C) 1C3, a ROSA 11–derived, dominant negative mutant clone;
(D) control chimera made of ROSA11 and AB2.2 cells; and (E) experimental chimera grown from mutant, 1C3, and wild-type, AB2.2
cells. Note that the mutant colonizes both cell layers and its fragments are localized in the central cavity. (F) Fused embryoid body from
a culture of mixed (ROSA11 and 1C3) aggregates. In this arrangement, no or little rescue of the dominant negative mutant could be ob-
served. Bars: (A–F) 25 mm. 
Li et al. 
 
FGF Signaling and the Basement Membrane
 
817
 
were similar to those with the mutant, as both formed co-
lumnar ectoderm and cavitated normally, but no visceral
endoderm could be distinguished (Fig. 7, D and F). Lack
of visceral endoderm differentiation by wild-type cells was
unusual, because these cells are constitutively capable of
visceral endoderm formation.
For the time being, more than one interpretation is possi-
ble for this phenomenon. Previous data suggest that FGF
signaling is required for endoderm differentiation (Wilder et
al., 1997; Arman et al., 1998). It is also possible that the sub-
endodermal BM is a default signal for columnar ectoderm
differentiation, and once the single endoderm layer has been
formed, it inhibits further endoderm differentiation. In addi-
tion, the particular externally added BM proteins might have
been inhibitory to the visceral endoderm. Although further
studies will have to clarify this problem, our results clearly
Figure 5. Localization of BM proteins in wild-type and mutant embryoid bodies. (A–N) Mature embryoid bodies after 7 d of culture.
(O–R) Early embryoid body differentiation (2 d of culture). Note that expression of specific proteins, in O–N, coincides with the incep-
tion of differentiation. (A–N) The first picture of each pair of panels shows a wild-type, whereas the second shows a mutant embryoid
body stained with the same reagent. Green false color: fluoresceinated phalloidin; red false color: specific proteins. Note that mutant
embryoid bodies (B, D, F, H, and L) express all BM proteins with the exception of laminin-a1 (J) and collagen IV (N). Lack of BM and
punctuated, diffuse label of BM receptors and BM-associated proteins in the mutant is in contrast to the absence of laminin-a1 (J) and
collagen IV (N). Dys, dystroglycan; Fn, fibronectin; int-a6, integrin-a6; Nid-1, nidogen-1; Lam-a1, laminin-a1; Perl, perlecan; Col-IV,
collagen IV. Bars: 40 mm.The Journal of Cell Biology, Volume 153, 2001 818
show that BM proteins can rescue ectoderm differentiation
and cavitation, even when FGF signaling is defective.
BM Proteins Activate a Normal Embryonic 
Differentiation Program
Besides Matrigel, which contains several BM proteins, a
highly purified laminin-1–nidogen complex also rescued
embryoid body differentiation. To explain how a purified
complex of two proteins can reconstitute the role of the
complex BM, we assumed that laminin-1 was bound by
precursors of the ectoderm. Laminin-1 then could activate
its receptors and facilitate the assembly of BM compo-
nents synthesized by the mutant. This assumption was sup-
ported by the finding that nidogen-1 (Fig. 8 A), perlecan
(Fig. 8 B), and fibronectin (Fig. 8 C) formed an overlap-
ping layer along the columnar ectoderm of laminin-treated
mutant embryoid bodies (Fig. 8). Next, we investigated
whether partial rescue by BM proteins activates genes that
are involved in early mammalian development.
Differentiation of mutant ES cells into columnar ecto-
derm model early epiblast differentiation. This step was
the salient event of the BM protein–induced partial rescue
of our mutation. To find molecular evidence beyond mor-
phological observations, first transcription of embryonic
globin, flk-1, and kit ligand (stem cell factor) was exam-
ined. However, Matrigel failed to induce these genes (not
shown). This was not surprising, if we consider that res-
cued embryoid bodies developed no endoderm. There-
fore, interaction between extraembryonic ectoderm and
visceral endoderm, which is required for embryonic he-
mopoiesis and angiogenesis, could not take place.
Next, genes involved in early mammalian development
were studied. Recent data associate important patterning
events with the visceral endoderm (Beddington and Rob-
ertson, 1999). Expression of several early developmental
genes, such as Brachyury, ptc, Gli-1, cripto-1, Otx-2, bone
morphogenetic protein (BMP)4, and BMP2, was undetect-
able, or unchanged after Matrigel treatment. This also
may have been due to loss of the normal interaction be-
tween visceral endoderm and epiblast. However, Matrigel
treatment did induce the transcription of a T-box gene,
Eomesodermin (Fig. 9).
Eomesodermin is the earliest pan-mesodermal marker of
Xenopus embryogenesis. It activates several mesodermal
transcription factors and its overexpression leads to the for-
mation of a partial secondary axis (Ryan et al., 1996). Its
mammalian orthologue, mEomes, is first expressed in the
trophectoderm and later in its derivative the extraembry-
onic ectoderm. During gastrulation, it is transcribed in the
primitive streak, in the nascent mesoderm, and in the ante-
rior visceral endoderm (Ciruna and Rossant, 1999). In
wild-type embryoid bodies, mEomes was expressed by the
columnar ectoderm (Fig. 9, A and B), whereas in the undif-
ferentiated mutant no mEomes transcripts could be de-
tected (Fig. 9 C). Importantly, however, mEomes was
activated in the ectoderm of Matrigel-treated mutant em-
bryoid bodies that passed a certain level of differentiation
(Fig. 9, D–F). In the three experiments testing mEomes ex-
pression, 30–40% of the Metrigel-treated embryoid bodies
underwent overt differentiation and around a third to one-
Figure 6. Transcription of genes encoding BM proteins. RNA
blot analysis. Wild-type or double-negative (dn) mutant ES cells
and embryoid bodies were harvested at day 0, 2, 3, and 6 of cul-
ture and subjected to RNA extraction and filter hybridization.
The blot was hybridized in succession to the DNA probes indi-
cated at the right. Laminin-a1, laminin-b1, and collagen a1 (IV)
are not or only weekly expressed in the mutant, whereas perle-
can, fibronectin, nidogen-1, and dystroglycan are transcribed to
similar extent in wild-type and mutant cultures.
Table III. Partial Rescue of Differentiation by Matrigel and by 
the Laminin-1–Nidogen Complex
Cells Treatment
Percentage of
differentiation No. counted
Wild-type 2 74 237
Mutant 2 4 434
Mutant 4% Matrigel for 24 h 67 124
Mutant 50 mg/ml laminin-1 for 24 h 30 164
Table IV. 100–10,000-fold Excess of Growth Factors Is 
Insufficient to Rescue the Dominant Negative FGFR Mutant
Growth factors
Approximate concentration
in growth factor–reduced
Matrigel
Growth factor added
to mutant
(ng/ml)
Difference of
concentration*
FGF2 0.004 pg/ml 25 6.25 3 103
EGF 20 pg/ml 10 5 3 102
Insulin 0.2 ng/ml 20 1 3 102
PDGF-BB 0.00 ng/ml 20 2 3 104
*Growth factors were added to mutant cultures at day 0 and their concentration was
maintained throughout the culture until day 5. No signs of differentiation could be ob-
served as a result of these treatments.Li et al. FGF Signaling and the Basement Membrane 819
half contained numerous mEomes-positive cells. Gene ex-
pression was restricted to internal cells developing into co-
lumnar ectoderm surrounding a nascent (Fig. 9, D and E)
or more advanced central cavity (Fig. 9 F).
Discussion
The Mutant Defect Resides in an Extracellular
Product of FGF Signaling
We studied the role of FGF signaling in embryoid body
differentiation by introducing a truncated FGFR cDNA
into ES cells. This dominant negative mutation was pre-
ferred to isotype-specific gene targeting, because ES cells
homozygous for mutant alleles of Fgfr1 or Fgfr2 have the
potential to differentiate (Deng et al., 1994; and our
unpublished results). Dominant negative FGFR muta-
tions have broader effects than mutations of individual
FGFR isotypes, because truncated FGFR monomers can
inhibit multiple FGFR isotypes through heterodimeriza-
tion (Ueno et al., 1992). It is of relevance that in a previous
study we detected transcripts of all four FGFR in differen-
tiating embryoid bodies (Chen et al., 2000).
Our dominant negative FGFR mutation abolished differ-
entiation of both cell layers of the embryoid body, suggest-
ing by extrapolation that FGF signaling is required for the
differentiation of the first embryonic cell lineages (Chen et
al., 2000). The decisive observation of this study was that if
mutant ES cells came in contact with extracellular products
of differentiating wild-type cells, they could contribute to
both cell layers of the embryoid body and participated in
cavitation. It follows that an extracellular FGFR-dependent
product or products are involved in the induction of embry-
oid body differentiation. The results presented here iden-
tify at least one of these products with the subepithelial
BM. The following lead to these conclusions: (a) the muta-
tion inhibited laminin-1 and collagen a1 (IV) synthesis; (b)
purified laminin-1 rescued ectoderm differentiation and
cavitation; and (c) externally added BM proteins activated
a program of early vertebrate development.
Figure 7. Partial rescue of
the mutant by Matrigel or by
purified laminin-1–nidogen
complex. (A) Untreated mu-
tant (mut); (B) untreated
wild-type (wt); (C and D)
mutant and wild-type, treated
with Matrigel (Matri); and (E
and F) mutant and wild-type,
treated with laminin-1 (Lam-
1)–nidogen complex. Note
that BM protein–treated mu-
tant (C and E) and wild-type
(D and F) embryoid bodies
cavitate and form colum-
nar ectoderm, but both fails
to form visceral endoderm.
Control and untreated mu-
tant harvested after 6 d of cul-
ture. Matrigel- and laminin-
treated cultures harvested at
day 7. cav, cavitation; ce, co-
lumnar ectoderm; nf, ne-
crotic focus; rg, residual gel
(Matrigel or laminin). Bars:
(A, B, C, D, and F) 40 mm.The Journal of Cell Biology, Volume 153, 2001 820
Defective Laminin-1 and Collagen IV 
Synthesis in the Mutant
Investigating the molecular defect of the mutation re-
vealed that mutant-derived embryoid bodies form no BM.
Nevertheless, several BM proteins and their receptors
were expressed by the mutant, albeit in a disorganized
manner, whereas laminin-1 and collagen IV were absent at
both the protein and mRNA levels. Laminin-1 and col-
lagen IV are the network-forming elements of the BM
(Colognato and Yurchenco, 2000). As the BM is required
for epithelial differentiation (see Introduction), loss of dif-
ferentiation in our mutation was likely to be due to loss of
BM assembly.
Figure 8. BM assembly on the surface of rescued mutant embryoid bodies. 1C3 mutant embryoid bodies were treated with purified
laminin-1–nidogen complex, as described in the text and Materials and Methods. Treated embryoid bodies were stained on the sixth day
of culture with phalloidin (green) and the ECM-specific antibodies (red). Specific staining: (A) nidogen-1, (B) perlecan, and (C) fi-
bronectin. Arrows point to cavity formation and to the adjacent columnar ectoderm. Note that the BM-related proteins are situated on
the surface of the embryoid body, with no visible external endoderm. Bars: (A and C) 40 mm; (B) 60 mm.
Figure 9. Externally added Matrigel induces Eomesodermin transcription. In situ hybridization with mEomes. (A and B) Wild-type;
(C) dominant negative mutant; (D–F) Matrigel-treated mutant. Note that both wild-type and rescued mutant embryoid bodies express
mEomes in the columnar ectoderm and in internal cells that presumably differentiate into columnar ectoderm, whereas no mEomes
transcription can be detected in the untreated mutant. The figures derive from three experiments, harvested at day 6. The frequency of
Matrigel-induced differentiation was between 30 and 40% and overt mEomes expression was detected in the more advanced third or
half. cav, cavity; ec, columnar ectoderm; en, visceral endoderm. Bar: 25 mm.Li et al. FGF Signaling and the Basement Membrane 821
Coordinate loss of laminin-1 and collagen-IV synthesis
was reminiscent of their coordinate induction by retinoic
acid in F9 teratocarcinoma cells (Kleinman et al., 1987), or
by myogenic factors in differentiating myoblasts (Kroll et
al., 1994). It follows that abrogation by loss of FGFR func-
tion and induction by physiological inducers may affect
similar mechanisms. FGF-induced laminin synthesis in
neuroepithelium cultures also points in this direction
(Drago et al., 1991). However, the pathway between FGF
signaling, laminin-1, and collagen IV synthesis is yet to be
described. As the FGF system and both laminins and col-
lagen IV have multiple isoforms, this appears to be a
daunting task. Our ongoing effort to clarify the connection
of FGF signaling with BM assembly relies on previous re-
sults suggesting that our mutant embryoid bodies are de-
fective in Akt/PKB activation (Chen et al., 2000). Prelimi-
nary results indicate that constitutively active PI-3 kinase
p110 or Akt/PKB increase laminin-g1 and collagen-a1
(IV) transcription.
Partial Rescue of Ectoderm Differentiation 
by BM Proteins
Rescue of epithelial differentiation in mixed cultures by
extracellular components of FGF signaling, or by addition
of BM proteins to mutant ES cells, both pointed to the
ECM’s role in epithelial differentiation. Numerous studies
demonstrate that BM proteins are required for epithelial
differentiation. Antibodies specific to the dystroglycan
binding site of laminin-a1 inhibit epithelial differentiation
during kidney and salivary gland development (Durbeej et
al., 1995; Kadoya et al., 1995). Loss of function mutations
of dystroglycan (Williamson et al., 1997), integrin-b1
(Fassler et al., 1995; Stephens et al., 1995), and laminin-g1
(Smyth et al., 1999) cause early postimplantation lethality.
ES cells homozygous for these mutations form embryoid
bodies with defective visceral endoderm. However, they
still express certain signs of differentiation (Henry and
Campbell, 1998; Aumailley et al., 2000). Murray and
Edgar showed that embryoid bodies derived from laminin-
g12/2 ES cells have no detectable BM, do not undergo ec-
toderm differentiation and cavitation, but display a degree
of visceral endoderm differentiation (Murray and Edgar,
2000). It is possible that compound mutations of more
than one BM proteins should result in even more severe
defects.
This study describes two experimental arrangements
that rescued the dominant negative FGFR mutation. In
mixed cultures, mutant-derived ES cells contributed to
both cell layers, whereas externally added BM proteins in-
duced ectoderm differentiation, but seemed to inhibit vis-
ceral endoderm formation. The most significant difference
between rescue by wild-type cells or by external BM pro-
teins is that wild-type cells in mixed cultures sustain FGF
signaling, which is absent in cultures of BM protein–
treated mutant cells. Hence, we conclude that FGF sig-
naling supplies additional differentiation signals beyond
those involved in BM assembly. Indeed, FGF signaling is
required for primitive endoderm differentiation, which is
the precursor of the visceral endoderm (Wilder et al.,
1997; Arman et al., 1998).
Taking these data together, one can outline a series of
steps leading to embryoid body differentiation and early
embryonic development. Aggregation of ES cells and the
compaction of the morula are controlled by the E-cad-
herin–b-catenin pathway (Larue et al., 1994). Endoderm
differentiation in ES cell aggregates or blastocysts requires
FGF signaling (Wilder et al., 1997; Arman et al., 1998). As
embryoid bodies express multiple FGFR (Chen et al.,
2000), this is likely to be a complex process. FGF signaling
activates the genes encoding laminin-1 and collagen IV in
the differentiating endoderm, leading to BM assembly and
the induction of ectoderm differentiation. The ectoderm
anchors in the subendodermal BM and cells that fail to at-
tach to it undergo apoptotic cavitation (Coucouvanis and
Martin, 1995). Besides its structural and antiapoptotic ef-
fects, the subendodermal BM may contribute to differenti-
ation in two nonexclusive ways, via its own signaling
receptors, and/or as a platform presenting signaling mole-
cules to the receptors of adjacent cells.
External BM Proteins Activate mEomes,
a Gene Active in Mesoderm Induction
Laminin-1–treated embryoid bodies display several over-
lapping BM proteins on their surface. Their binding is
likely to be connected to the rearrangement of receptors
in the differentiating ectoderm. It follows that signaling
through receptors for laminin-1 may induce changes con-
ducive to increased BM protein synthesis, receptor expres-
sion, and BM assembly.
Beyond the morphological detection of BM assembly
and epithelial differentiation, we sought evidence for the
activation of normal embryonic differentiation by exter-
nally added BM proteins. Among several markers, which
were expressed constitutively in mutant and wild-type and
presumably required interaction between the visceral en-
doderm and the ectoderm, Eomesodermin, a pan-meso-
dermal marker, was activated as the result of BM protein–
induced ectoderm differentiation. mEomes is expressed in
the trophectoderm-derived extraembryonic ectoderm of
the mouse embryo (Ciruna and Rossant, 1999), and it is
later involved in embryonic hemopoiesis and vasculogene-
sis. Transcription of mEomes in ES cell–derived embryoid
bodies, which contain no trophectoderm derivatives, may
be connected to the embryoid body’s propensity for he-
mopoiesis and vasculogenesis. Activation of this pan-
mesodermal gene in ES cell–derived embryoid bodies cor-
responds to the epithelialization of the early epiblast into
the columnar ectoderm of the egg cylinder embryo. It fol-
lows that mEomes expression induced by BM proteins in
the ectoderm of the embryoid body belongs to the pro-
grams of early vertebrate development.
The central finding emerging from this study is that FGF
signaling is required for the expression of laminin-1 and
collagen-a1 (IV), which contribute to BM assembly and as
a consequence to ectoderm differentiation. Similar pro-
cesses may be important for the formation of early embry-
onic cell layers and for cell to matrix interactions during
organogenesis and other physiological and pathological
processes that require FGF signaling and the assembly or
modification of the BM.
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